Tonghua Dongbao Pharmaceutical Statistics

Total Valuation

Tonghua Dongbao Pharmaceutical has a market cap or net worth of CNY 17.41 billion. The enterprise value is 17.53 billion.

Market Cap	17.41B
Enterprise Value	17.53B

Important Dates

The last earnings date was Friday, October 25, 2024.

Earnings Date	Oct 25, 2024
Ex-Dividend Date	May 23, 2024

Share Statistics

Tonghua Dongbao Pharmaceutical has 1.95 billion shares outstanding. The number of shares has increased by 6.93% in one year.

Current Share Class	n/a
Shares Outstanding	1.95B
Shares Change (YoY)	+6.93%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	1.15%
Owned by Institutions (%)	11.61%
Float	1.15B

Valuation Ratios

The trailing PE ratio is 55.95 and the forward PE ratio is 23.81. Tonghua Dongbao Pharmaceutical's PEG ratio is 2.16.

PE Ratio	55.95
Forward PE	23.81
PS Ratio	7.85
PB Ratio	2.71
P/TBV Ratio	n/a
P/FCF Ratio	233.62
P/OCF Ratio	n/a
PEG Ratio	2.16

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 22.82, with an EV/FCF ratio of 235.29.

EV / Earnings	51.37
EV / Sales	7.21
EV / EBITDA	22.82
EV / EBIT	31.41
EV / FCF	235.29

Financial Position

The company has a current ratio of 4.30, with a Debt / Equity ratio of 0.08.

Current Ratio	4.30
Quick Ratio	2.32
Debt / Equity	0.08
Debt / EBITDA	0.64
Debt / FCF	6.61
Interest Coverage	40.00

Financial Efficiency

Return on equity (ROE) is 5.14% and return on invested capital (ROIC) is 5.02%.

Return on Equity (ROE)	5.14%
Return on Assets (ROA)	4.87%
Return on Capital (ROIC)	5.02%
Revenue Per Employee	760,839
Profits Per Employee	106,792
Employee Count	3,196
Asset Turnover	0.34
Inventory Turnover	0.74

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -25.37% in the last 52 weeks. The beta is 0.25, so Tonghua Dongbao Pharmaceutical's price volatility has been lower than the market average.

Beta (5Y)	0.25
52-Week Price Change	-25.37%
50-Day Moving Average	8.01
200-Day Moving Average	8.99
Relative Strength Index (RSI)	63.66
Average Volume (20 Days)	30,486,608

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Tonghua Dongbao Pharmaceutical had revenue of CNY 2.43 billion and earned 341.31 million in profits. Earnings per share was 0.16.

Revenue	2.43B
Gross Profit	1.88B
Operating Income	558.16M
Pretax Income	372.20M
Net Income	341.31M
EBITDA	768.43M
EBIT	558.16M
Earnings Per Share (EPS)	0.16

Full Income Statement

Balance Sheet

The company has 372.83 million in cash and 492.75 million in debt, giving a net cash position of -119.92 million or -0.06 per share.

Cash & Cash Equivalents	372.83M
Total Debt	492.75M
Net Cash	-119.92M
Net Cash Per Share	-0.06
Equity (Book Value)	6.43B
Book Value Per Share	3.30
Working Capital	1.50B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 613.51 million and capital expenditures -538.99 million, giving a free cash flow of 74.51 million.

Operating Cash Flow	613.51M
Capital Expenditures	-538.99M
Free Cash Flow	74.51M
FCF Per Share	0.04

Full Cash Flow Statement

Margins

Gross margin is 77.49%, with operating and profit margins of 22.95% and 14.04%.

Gross Margin	77.49%
Operating Margin	22.95%
Pretax Margin	15.31%
Profit Margin	14.04%
EBITDA Margin	31.60%
EBIT Margin	22.95%
FCF Margin	3.06%

Dividends & Yields

This stock pays an annual dividend of 0.25, which amounts to a dividend yield of 2.79%.

Dividend Per Share	0.25
Dividend Yield	2.79%
Dividend Growth (YoY)	-50.00%
Years of Dividend Growth	n/a
Payout Ratio	147.41%
Buyback Yield	-6.93%
Shareholder Yield	-4.15%
Earnings Yield	1.79%
FCF Yield	0.43%

Dividend Details

Stock Splits

The last stock split was on May 25, 2018. It was a forward split with a ratio of 1.2.

Last Split Date	May 25, 2018
Split Type	Forward
Split Ratio	1.2

Scores

Tonghua Dongbao Pharmaceutical has an Altman Z-Score of 18.28.

Altman Z-Score	18.28
Piotroski F-Score	n/a